Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 40 results for "dusa pharmaceuticals"

CT ORDER - DUSA PHARMACEUTICALS INC (0000879993) (Filer)

Form CT ORDER - Confidential treatment order SEC Accession No. 9999999997-16-026397 Filing Date 2016-10-13 2016-10-13 17:19:00 Filing Date Changed 2016-10-13 Document Format Files Mailing Address 25 UPTON DRIVE WILMINGTON MA ... SEC Filings, 1 month ago

Global Actinic Keratosis Market Report 2012-2022 - Analysis, Technologies & Forecasts - Vendors: Apotex, …

DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the report to their offering. Actinic keratosis (AK) is portrayed by skin papules, macules or plaques coming about because of delayed presentation to hurtful UV ...
 Yahoo! Finance2 weeks ago Research and Markets - Global Actinic Keratosis Market Analysis - Trends, Technologies & Opportunities Report..  ADVFN India2 weeks ago Actinic Keratosis Market is expected to reach USD 8,909.7 Mn by 2022, Credence Research  MyNewsDesk1 month ago
[x]  

iCAD Appoints Richard Christopher Executive Vice President and Chief Financial Officer

NASHUA, N.H., Nov. 08, 2016 (GLOBE NEWSWIRE) -- iCAD ( Nasdaq:ICAD ), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that ...
 BioSpace3 weeks ago iCAD appoints Richard C. Christopher as CFO  Post Online Media3 weeks ago
[x]  

Cystic Acne Market to Boost Sales of Topical Medications by ~10% Post 2016

(Before It's News) Market Research Future published a half cooked research report on Cystic Acne Market. The global market is expected to grow over the CAGR of around 10% during the period 2016 to 2021 . Market Highlights The Cystic Acne ...
 Before It's News1 month ago

Biofrontera overcomes combination product hurdles to enter US market

There are many moving parts for Biofrontera , a drug and device company specializing in sun-induced skin cancer. With just 60 employees, it has navigated E.U., and U.S., regulatory approval processes, bringing to market both a topical prescription ...
 MedCity News1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less